F68-17786-22655
3 vaccinations
6 coded responses
32 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 601 / IL
- Registered
- 2021-04-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
LCN-21234-67569
Child or adolescent in my care · Male · 2022-02-10
2JA-82453-66392
Child or adolescent in my care · Male · 2022-02-10
Timeline
-
2021-04-07
Dose 1 — Moderna
-
2021-04-13
Registered in v-safe
- 2021-04-13
- 2021-04-14
- 2021-04-21
- 2021-04-29
-
2021-05-05
Dose 2 — Moderna
- 2021-05-05
-
2021-05-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-05-09
- 2021-05-10
- 2021-05-11
- 2021-05-12
- 2021-05-19
- 2021-05-26
-
2021-06-02
Survey response — day 28, dose 2MedDRA: Fatigue, Headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Headache and fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-09
- 2021-06-16
- 2021-08-06
-
2021-11-03
Survey response — 6 months, dose 2MedDRA: Cough, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cough and congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-02-09
Dose 3 — Pfizer-BioNTech
-
2022-02-10
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache · Be unable to do your normal daily activitiesAdult check-in
- 2022-02-11
- 2022-02-12
- 2022-02-14
-
2022-02-18
Health check-in — day 7, dose 3Feeling: Good · Headache · Be unable to do your normal daily activitiesAdult check-in
- 2022-02-23
- 2022-03-02
-
2022-03-09
Survey response — day 28, dose 3MedDRA: Fatigue, Headache — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Extreme fatigue and bad headaches.MedDRA releases: 2024-11 · check-in free text available
- 2022-03-18
-
2022-03-23
Survey response — day 42, dose 3MedDRA: Dysmenorrhoea, Heavy menstrual bleeding, Menstrual clots — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Very heavy menstruation with severe cramps and large clots.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-11
-
2022-08-10
Survey response — 6 months, dose 3MedDRA: Chills, Cough, Pyrexia, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Fever, chills, runny nose, coughMedDRA releases: 2024-11 · check-in free text available
-
2023-02-09
Survey response — 12 months, dose 3MedDRA: Delivery, Gestational hypertension, Hypertension — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, HospitalizationMedDRA releases: 2024-11
-
2023-02-09
Report sent to call center — 12 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
- 2023-02-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-07 | Moderna | |
| 2 | 2021-05-05 | Moderna | |
| 3 | 2022-02-09 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 8 — day 28, dose 2
Symptoms: Headache and fatigue
Release 10 — 6 months, dose 2
Symptoms: Cough and congestion
Release 11 — day 28, dose 3
Symptoms: Extreme fatigue and bad headaches.
Release 11 — day 42, dose 3
Symptoms: Very heavy menstruation with severe cramps and large clots.
Release 12 — 6 months, dose 3
Symptoms: Fever, chills, runny nose, cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Delivery | · | · | ✓ |
| SD | Dysmenorrhoea | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Gestational hypertension | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SD | Hypertension | · | · | ✓ |
| SD | Menstrual clots | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release